$PDM

PDM Stock Fund Price and Chart — NYSE:PDM

This page provides a detailed overview of Piedmont Realty Trust, Inc. (NYSE: PDM), including its stock price performance, financial statistics, upcoming earnings, and key company information. It also includes analyst ratings, related stock ideas, and bond and ETF holdings related to PDM. The company, founded in 1997, engages in the ownership, management, development, and operation of office properties across several U.S. geographical segments.

Original reporting
Published Mar 15, 2026, 8:52 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 15, 2026, 9:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
PDM Stock Fund Price and Chart — NYSE:PDM — source image
Decision brief

The 30-second read

$PDMNeutralLow
01

Why it matters

The news consolidates existing information; no new developments are reported that could significantly influence stock price.

02

Market read

The news has limited immediate trading impact but is relevant for long-term investors monitoring sector fundamentals.

03

What to watch

Potential upcoming earnings surprises or macroeconomic shifts could alter outlook.

Timing: Long-term

Background

Piedmont Realty Trust, Inc. specializes in owning and managing office properties across the U.S., with a history dating back to 1997.

Company-level read

Ticker impact

$PDMNeutralMedium confidence
Context

Primary focus of the news, detailed overview of Piedmont Realty Trust, Inc.

Expected impact

Minimal short-term price movement expected; long-term outlook remains unchanged.

Evidence & confidence

The news is informational without new catalysts or significant market-moving signals, leading to a neutral outlook.

Market effects

Limited impact on the real estate sector; PDM's performance may influence sector sentiment marginally.

No significant regional effects anticipated.

Minimal relevance to global markets.

Counterpoint

If broader real estate sector faces headwinds, PDM could underperform despite neutral news.

Key entities

  • Piedmont Realty Trust, Inc.

    A real estate investment trust focusing on office properties.

Related articles

$PDMMed

Piedmont Office Realty Trust, Inc. Q2 2026 Earnings Call Summary

Strategic Performance and Market Dynamics Management attributes the strong quarterly performance to a structural shift in the office market where demand is now outpacing the supply of high-quality, amenitized buildings. The company has successfully implemented asking rate increases of over 15% across a substantial portion of the portfolio, reflecting significant pricing power in core submarkets.

$PDMMed

Piedmont Realty Trust Q2 Earnings Call Highlights

Piedmont Realty Trust (PDM) reported Q2 earnings call highlights. Expansions totaled 9, adding 22,000 sq ft, with no contractions. Weighted average starting cash rent rose 5% to $43.79/sq ft. Net effective rent rose to $25.56/sq ft, over 20% above trailing 12-month. Same-store cash NOI grew 9% in Q2 and 10% in first half. Piedmont refinanced a term loan to $400M, extending maturity to May 2031.

$PDMMed

Piedmont Realty Trust: Q2 Earnings Snapshot

Piedmont Realty Trust (PDM) reported Q2 funds from operations of $47.9 million, or 38 cents per share, alongside a Q2 loss of $11.1 million, or 9 cents per share. The REIT said revenue was $144.1 million. It expects full-year funds from operations of $1.50 to $1.55 per share.

$PDMLow

Piedmont Realty Trust, Inc. (PDM): Results of Operations and Financial Condition

Piedmont Realty Trust, Inc. (PDM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pdm63026ex991q22026ersuppl.htm Q2 2026 EARNINGS RELEASE AND SUPPLEMENTAL PACKAGE Document EXHIBIT 99.1 Piedmont Realty Trust TM Earnings Release and Supplemental Information Index Page Page Introduction Diversification Tables Forward-Looking Statements 3 Tenant Diversif

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.